Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Letters   |    
Citalopram in Agitated and Delusional Demented Patients Who Failed Treatment With Antipsychotic Agents
Nabil Kotbi, M.D.; Arun Singh, D.O.; Jerard Kneifati-Hayek, B.A.; Anna Odom, Ph.D.; George Alexopoulos, M.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2014;26:E62. doi:10.1176/appi.neuropsych.13060122
View Author and Article Information

Dr. Alexopoulos has received grant support from Forest; he has served as a consultant to Forest, Hoffman-La Roche, Janssen, Lilly, Lundbeck, Pfizer, and Otsuka; and he currently serves or has served on the speakers' bureau of AstraZeneca, Avanir, Forest, Merck, Novartis, Sunovion, and Takeda-Lundbeck. All other authors report no financial relationships with commercial interests.

Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY

Send correspondence to Dr. Odom; e-mail: ano9021@med.cornell.edu

Copyright © 2014 by the American Psychiatric Association


To the Editor: Agitation is a common, difficult to treat complication of dementing disorders. Optimal management of agitation consists of treatment of precipitants of agitation, including undiagnosed medical problems, pain, drug toxicity, environmental triggers, poor sleep, delirium, and depression.1 When precipitants of agitation are either absent or successfully treated, pharmacological treatment may target the syndrome of agitation. Antipsychotic agents are recommended as the first line treatment for this purpose. However, antipsychotic drugs have modest efficacy2 and entail safety concerns including orthostasis, drowsiness, extrapyramidal syndromes, incoordination, metabolic syndrome, prolonged QTc in EKG, and cerebrovascular events.3

Figures in this Article

First Page Preview

View Large
First page PDF preview
Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).



Salzman  C;  Jeste  DV;  Meyer  RE  et al:  Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.  J Clin Psychiatry 2008; 69:889–898
[CrossRef] | [PubMed]
Sink  KM;  Holden  KF;  Yaffe  K:  Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.  JAMA 2005; 293:596–608
[CrossRef] | [PubMed]
Steinberg  M;  Lyketsos  CG:  Atypical antipsychotic use in patients with dementia: managing safety concerns.  Am J Psychiatry 2012; 169:900–906
[CrossRef] | [PubMed]
Pollock  BG;  Mulsant  BH;  Rosen  J  et al:  Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.  Am J Psychiatry 2002; 159:460–465
[CrossRef] | [PubMed]
Pollock  BG;  Mulsant  BH;  Rosen  J  et al:  A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.  Am J Geriatr Psychiatry 2007; 15:942–952
[CrossRef] | [PubMed]
References Container

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content
Textbook of Traumatic Brain Injury, 2nd Edition > Chapter 35.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 9.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 5.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 62.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles